We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+3.15%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$3.85B
AUM Growth
-$153M
Cap. Flow
-$306M
Cap. Flow %
-7.96%
Top 10 Hldgs %
17.74%
Holding
705
New
68
Increased
289
Reduced
229
Closed
52

Top Buys

Rank Stock Value
1
ABT icon
Abbott
ABT
+$22.5M
2
AET
Aetna Inc
AET
+$21.5M
3
JNJ icon
Johnson & Johnson
JNJ
+$20.4M
4
ADI icon
Analog Devices
ADI
+$19.4M
5
CMI icon
Cummins
CMI
+$17.3M

Top Sells

Rank Stock Value
1
INTC icon
Intel
INTC
+$43.9M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$40.1M
3
ABBV icon
AbbVie
ABBV
+$37.1M
4
GILD icon
Gilead Sciences
GILD
+$24.2M
5
PH icon
Parker-Hannifin
PH
+$22.4M

Sector Composition

Rank Sector Weight
1 Healthcare 24.55%
2 Financials 13.06%
3 Technology 10.24%
4 Consumer Staples 10.19%
5 Communication Services 9.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMGN icon
1
Amgen
AMGN
$198B
$89.6M 2.33%
588,715
-111,618
-16% -$17.4M
JNJ icon
2
Johnson & Johnson
JNJ
$603B
$88.4M 2.3%
728,944
+179,216
+33% +$20.4M
GILD icon
3
Gilead Sciences
GILD
$162B
$76.3M 1.98%
914,184
-272,601
-23% -$24.2M
GOOGL icon
4
Alphabet (Google) Class A
GOOGL
$4.24T
$71.5M 1.86%
2,033,300
-1,092,780
-35% -$40.1M
PEP icon
5
PepsiCo
PEP
$184B
$69.4M 1.8%
654,969
-126,121
-16% -$13M
PG icon
6
Procter & Gamble
PG
$345B
$62.2M 1.62%
734,565
-120,132
-14% -$9.86M
AMZN icon
7
Amazon
AMZN
$2.66T
$60.5M 1.57%
1,689,600
+17,160
+1% +$580K
XOM icon
8
ExxonMobil
XOM
$629B
$59.3M 1.54%
632,231
+52,384
+9% +$4.63M
AAPL icon
9
Apple
AAPL
$4.81T
$55.9M 1.45%
2,340,636
-95,836
-4% -$2.38M
META icon
10
Meta Platforms (Facebook)
META
$1.63T
$49.2M 1.28%
430,329
+24,797
+6% +$2.86M
PFE icon
11
Pfizer
PFE
$142B
$47.3M 1.23%
1,416,619
+159,956
+13% +$5.11M
CSCO icon
12
Cisco
CSCO
$442B
$46.6M 1.21%
1,623,437
+476,822
+42% +$13.4M
MSFT icon
13
Microsoft
MSFT
$2.95T
$44.6M 1.16%
871,604
-102,939
-11% -$5.35M
CELG
14
DELISTED
Celgene Corp
CELG
$43.4M 1.13%
440,062
-140,577
-24% -$14.5M
T icon
15
AT&T
T
$155B
$42.7M 1.11%
1,308,831
-106,051
-7% -$3.16M
BIIB icon
16
Biogen
BIIB
$30B
$40.1M 1.04%
165,861
-15,539
-9% -$4.1M
VZ icon
17
Verizon
VZ
$183B
$39.8M 1.03%
712,190
-25,653
-3% -$1.33M
MMM icon
18
3M
MMM
$89.1B
$38.3M 0.99%
261,223
-2,002
-0.8% -$282K
ADI icon
19
Analog Devices
ADI
$186B
$35.3M 0.92%
623,417
+339,513
+120% +$19.4M
REGN icon
20
Regeneron Pharmaceuticals
REGN
$70.8B
$33.2M 0.86%
95,104
+24,146
+34% +$9.3M
JPM icon
21
JPMorgan Chase
JPM
$918B
$30.9M 0.8%
497,441
+189,240
+61% +$11.8M
V icon
22
Visa
V
$677B
$30.3M 0.79%
408,823
+63,232
+18% +$4.95M
PM icon
23
Philip Morris
PM
$293B
$29.8M 0.77%
292,527
+6,338
+2% +$632K
BMY icon
24
Bristol-Myers Squibb
BMY
$124B
$29.3M 0.76%
398,360
-28,691
-7% -$2.03M
GE icon
25
GE Aerospace
GE
$353B
$29.3M 0.76%
193,942
+72,932
+60% +$10.6M

Similar funds

Candriam SCA's Q2 2016 Portfolio in Review

As of Q2 2016, Candriam SCA held 705 positions worth $3.85B, down 3.8% from $4B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Candriam SCA withdrew a net $306M in Q2 2016, closing 52 positions and reducing 229 holdings. Its most notable exit was TIME WARNER CABLE INC NEW COM STK, an estimated $9.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 24% a quarter earlier, followed by Financials and Technology.

Against the trend, Candriam SCA opened a new position in NiSource worth $14.5M.

  • Candriam SCA's largest Q2 2016 buy was NiSource: 547,430 shares worth $14.5M.
  • Candriam SCA added most to Abbott in Q2 2016, an estimated $22.5M increase.
  • Candriam SCA's biggest Q2 2016 reduction was Intel, cutting an estimated $43.9M.
  • Candriam SCA fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $9.2M.
  • Candriam SCA's ten largest holdings make up 18% of its $3.85B portfolio in Q2 2016.
  • Candriam SCA opened 68 new positions and closed 52 in Q2 2016.
  • Candriam SCA's portfolio value fell 3.8% quarter-over-quarter to $3.85B.

Based on Candriam SCA's 13F filing for Q2 2016, filed 26 Jul 2016.